Blood lipids Sample Clauses

Blood lipids. Analyses of TC, HDL-C and TAG were carried out by Xx Xxx Xxxxxxxx at the Department of Clinical Biochemistry, King’s College Hospital. TC was determined using an enzymatic method using cholesterol esterase, cholesterol oxidase and peroxidase in a chemiluminescent reaction to produce a red quinoneimine dye. The increase in absorbance was measured as an endpoint reaction at 505/694 nm. For RISCK samples, inter-assay CVs were 1.1, 1.5 and 1.0 at 3.9, 5.2 and 5.7 mmol/L respectively. For MARINA samples inter-assay CVs were 1.1, 1.5 and 1.0 % at 3.9, 5.1 and 5.7 mmol/L respectively. HDL-C was analysed using a two-step automated procedure (Bayer Advia Direct HDL-C method). For RISCK samples CVs were 2.2, 2.1 and 2.5 at 0.91, 1.39 and 1.95 mmol/L respectively and for MARINA samples CVs were 2.2, 2.1 and 2.5 % at concentrations of 0.91, 1.39 and 1.95 mmol/L respectively. TAG was measured using an enzymatic assay (The Bayer Advia method). For RISCK samples, CVs were 2.5 and 1.5 at 1.32 and 2.36 mmol/L respectively and for MARINA samples CVs were 2.5 and 1.5 % at concentrations of 1.32 and 2.36 mmol/L respectively. LDL-C was calculated using the Friedwald formula if fasting plasma TG concentrations were < 4.49 mmol/L. The formula used was: LDL-C = TC - HDL-C - (TAG / 2.2) (Xxxxxxxxxx et al, 1972). For RISCK samples, plasma Apo B and Apo A1 were measured at the University of Surrey using commercially available kits (Randox, UK) that employ immuno- turbidimetric assays. The proportion of small dense LDL was measured by ultracentrifugation of the LDL fraction on an iodixanol gradient at the University of Surrey. Fasted plasma phospholipid fatty acids were measured by GC at the University of Reading as described by (Xxxxx et al, 2009). For MARINA samples, erythrocyte membrane phospholipid fatty acid composition measured using capillary gas liquid chromatography as described by Xxxxxxx et al. (2006). Mean inter-assay and intra-assay CVs were 3% and 2% respectively.
AutoNDA by SimpleDocs

Related to Blood lipids

  • Blood Donors The Employer agrees to allow the necessary time off with no loss of pay to employees who are called upon to donate blood to the Canadian Blood Services.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Chemical Dependency Alcoholism and drug addiction shall be recognized as an illness. However, sick leave pay for treatment of such illness shall be contingent upon two conditions: 1) the employee must undergo an evaluation by a licensed alcohol and drug counselor or substance abuse professional, and 2) the employee, during or following the above care, must participate in a prescribed program of treatment and rehabilitation approved by the Employer in consultation with the Employer's health care provider.

  • Blood Donation Whenever an employee is called by a Blood Bank to donate blood during the work day as a result of a medical emergency requiring immediate transfusion, rather than blood replacement, that employee shall have the remainder of the day off without loss of pay.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Substance Abuse Program The SFMTA General Manager or designee will manage all aspects of the FTA-mandated Substance Abuse Program. He/she shall have appointing and removal authority over all personnel working for the Substance Abuse Program personnel, and shall be responsible for the supervision of the SAP.

  • SUBSTANCE ABUSE The dangers and costs that alcohol and other chemical abuses can create in the electrical contracting industry in terms of safety and productivity are significant. The parties to this Agreement resolve to combat chemical abuse in any form and agree that, to be effective, programs to eliminate substance abuse and impairment should contain a strong rehabilitation component. The local parties recognize that the implementation of a drug and alcohol policy and program must be subject to all applicable federal, state, and local laws and regulations. Such policies and programs must also be administered in accordance with accepted scientific principles, and must incorporate procedural safeguards to ensure fairness in application and protection of legitimate interests of privacy and confidentiality. To provide a drug-free workforce for the Electrical Construction Industry, each IBEW local union and NECA chapter shall implement an area-wide Substance Abuse Testing Policy. The policy shall include minimum standards as required by the IBEW and NECA. Should any of the required minimum standards fail to comply with federal, state, and/or local laws and regulations, they shall be modified by the local union and chapter to meet the requirements of those laws and regulations.

  • Blood Donations An employee may be granted leave with pay, up to a maximum of two (2) hours, for donating blood during regularly scheduled hours of work.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!